Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
-
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
-
Body Energy Club Unveils New Mobile App, Blending Convenience with Wellness and Growth
-
Anika Reports Third Quarter 2025 Financial Results
-
Avista Corp. Reports Strong Q3 2025 Financial Results, Confirms 2025 Earnings Guidance
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
-
New Crypto Mutuum Finance (MUTM) Nears $20M Raised as Phase 6 Hits 85% Allocation With V1 Ahead
-
Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics
-
Astec Reports Third Quarter 2025 Results
-
Aben Gold Receives Class 1 Quartz Approval to Conduct Exploration at Justin Gold Project
-
Secura Bio to Participate in the Jefferies Global Healthcare Conference in London
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Brink's Delivers Strong Third-Quarter Results
-
Orion Reports Improvement in Gross Margin and Profitability in Q2 2026; Reiterates FY 2026 Outlook
-
BioCryst to Present at Upcoming Investor Conference
-
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025
-
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
-
Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
-
Bullish Selects GenieAI as Portfolio and Risk Analytics Provider for Professional Trader Competition
-
Bocana Resources Corp. provides Corporate Update
-
Blue Gold Limited Secures $140m1 to Restart the 5.1m oz Bogoso & Prestea Mold mine, with new institutional investor committing $65m
-
Sachem Capital Reports Third Quarter 2025 Results
-
Microbix Addresses Cybersecurity Incident
-
Sprott Announces Third Quarter 2025 Results
-
PLAYBOY Announces Winter Issue Featuring Rare Vintage Images of Jane Birkin, 12 New Playmates, Kid Cudi, Sharon Stone and More, on Stands November 11, 2025
-
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
-
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
-
NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada
-
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
-
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
-
Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025
-
Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Electra Reactivates Construction at Cobalt Sulfate Refinery
-
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
-
HTVRONT A300 Auto Hat Heat Press Brings True Automation to Hat Making
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Ansys, Inc. Investors Who Received Synopsys, Inc. (NASDAQ: SNPS) Shares in Connection with Synopsys’s Acquisition of Ansys in July 2025
-
The 4K OLED Xencelabs Pen Display 16 Lite, Now Available
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket’s Acqui
-
Royalty Pharma Reports Third Quarter 2025 Results
-
ACM Research Reports Third Quarter 2025 Results
-
Tandym Group Launches ANDY – an AI Career Mentor Built into Tandym Catalyst™
-
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
-
Stella-Jones Announces Third Quarter Results
-
ScottsMiracle-Gro Reports Strong Fiscal 2025 Full-Year Results Driven by Robust Gross Margin Expansion and EPS Growth
-
Plug Power Begins 5 MW Electrolyzer Installation for H2 Hollandia, Set to Become the Largest Green Hydrogen Initiative in the Netherlands
-
Alpha Modus Files Patent-Infringement Lawsuit Against Adroit Worldwide Media (AWM) Over Cashierless and Smart-Shelf Technologies
-
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
-
MVP Ventures Closes $125 Million Fund II, Reporting Top 5% TVPI Performance and Expanding Its Founder-First Model
-
OTC Markets Group Welcomes Moon Inc. to OTCQX

